针对癌症患者和护理人员的多模组群体远程预康复:一个务实的多中心混合实施-有效性研究协议
Isabelle Doré1,2,3, Alexia Piché1,2, Corentin Montiel1,3
1Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.
Frontiers in oncology
|October 13, 2025
概括
这项研究介绍了coACTIF,这是一项针对癌症患者和他们的护理人员而设计的基于小组的多式联络远程预康计划. 该计划旨在通过整合虚拟炼和在线教育来改善健康,加速康复,并支持护理人员,以改善癌症护理.
科学领域:
- 在瘤学瘤学.
- 康复医学 康复医学 康复医学
- 数字健康数字健康
背景情况:
- 多模式预康复优化了癌症患者的健康和康复.
- 护理人员的支持至关重要,但可能会对护理人员的健康产生负面影响.
- 身体活动对于照顾者来说至关重要,以维持他们苛刻的角色.
研究的目的:
- 介绍coACTIF的协议,这是针对癌症患者和护理人员的第一个基于小组的多式联络远程预康计划.
- 评估这一创新性干预措施的实施效率.
主要方法:
- 实用,多中心,混合实施效率研究与前后后续混合方法设计.
- 干预包括虚拟监督小组练习和基于网络的教育平台.
- RE-AIM框架和CFIR用于评估加拿大北克省100个单位的实施和有效性.
主要成果:
- 在干预前,干预后和手术后90天评估的功能健康和健康结果.
- 采访中的定性数据将识别实施障碍和促进者.
- 该研究旨在提供关于癌症护理远程预康复的真实证据.
结论:
- coACTIF有可能优化癌症患者和护理人员的体验.
- 该干预旨在加速癌症连续体早期的行为变化.
- 这些发现将为跨越不同癌症护理环境的扩大策略提供信息.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...


